Journal article
Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor
Chembiochem : a European journal of chemical biology, Vol.21(5), pp.712-722
03/02/2020
DOI: 10.1002/cbic.201900434
PMCID: PMC7042063
PMID: 31449350
Abstract
The deubiquitinase (DUB) ubiquitin C-terminal hydrolase L1 (UCHL1) is expressed primarily in the central nervous system under normal physiological conditions. However, UCHL1 is overexpressed in various aggressive forms of cancer with strong evidence supporting UCHL1 as an oncogene in lung, glioma, and blood cancers. In particular, the level of UCHL1 expression in these cancers correlates with increased invasiveness and metastatic behavior, as well as poor patient prognosis. Although UCHL1 is considered an oncogene with potential as a therapeutic target, there remains a significant lack of useful small-molecule probes to pharmacologically validate in vivo targeting of the enzyme. Herein, we describe the characterization of a new covalent cyanopyrrolidine-based UCHL1 inhibitory scaffold in biochemical and cellular studies to better understand the utility of this inhibitor in elucidating the role of UCHL1 in cancer biology.
Details
- Title: Subtitle
- Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor
- Creators
- Aaron D Krabill - Purdue University West LafayetteHao Chen - Purdue University West LafayetteSajjad Hussain - Mayo ClinicChao Feng - Purdue University West LafayetteAmmara Abdullah - Purdue University West LafayetteChittaranjan Das - Purdue University NorthwestUma K Aryal - Purdue University West LafayetteCarol Beth Post - Purdue University West LafayetteMichael K Wendt - Purdue University West LafayettePaul J Galardy - Mayo ClinicDaniel P Flaherty - Purdue University West Lafayette
- Resource Type
- Journal article
- Publication Details
- Chembiochem : a European journal of chemical biology, Vol.21(5), pp.712-722
- DOI
- 10.1002/cbic.201900434
- PMID
- 31449350
- PMCID
- PMC7042063
- NLM abbreviation
- Chembiochem
- ISSN
- 1439-4227
- eISSN
- 1439-7633
- Grant note
- R01 GM039478 / NIGMS NIH HHS P30 CA023168 / NCI NIH HHS
- Language
- English
- Date published
- 03/02/2020
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984460330902771
Metrics
14 Record Views